Literature DB >> 30121215

Clinical characteristics of PD patients with LRRK2 G2385R and R1628P variants.

Dongxiao Liang1, Li Shu1, Hongxu Pan1, Qian Xu2, Jifeng Guo3, Xinxiang Yan2, Beisha Tang4, Qiying Sun5.   

Abstract

LRRK2 is the most common genetic cause of PD. G2385R and R1628 P variants are the most common variants of LRRK2 in Chinese populations. Consensus on the clinical features of G2385R and R1628 P related PD has not been reached yet, although it had been widely studied. In our study, genotype analyses were conducted on 721 PD patients of Chinese origin. A total of 62 G2385R carriers, 32 R1628 P carriers and 623 idiopathic PD patients underwent the following clinical feature analysis. Motor symptoms, non-motor symptoms and co-morbidities were the targeted features to be analyzed. As a result, Neither the G2385R nor the R1628 P carriers showed significant clinical feature differences when compared to the idiopathic PD patients, so did the comparison between the G2385R and the R1628 P carriers. In conclusion, the clinical features of PD patients with LRRK2 G2385R or R1628 P variants were similar to those of idiopathic PD.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinical; LRRK2 G2385R; Parkinson’s disease; Phenotype; R1628P

Mesh:

Substances:

Year:  2018        PMID: 30121215     DOI: 10.1016/j.neulet.2018.08.015

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

Review 1.  Genetic heterogeneity on sleep disorders in Parkinson's disease: a systematic review and meta-analysis.

Authors:  Jingxuan Huang; Yangfan Cheng; Chunyu Li; Huifang Shang
Journal:  Transl Neurodegener       Date:  2022-04-08       Impact factor: 8.014

2.  GCH1 variants contribute to the risk and earlier age-at-onset of Parkinson's disease: a two-cohort case-control study.

Authors:  Hong-Xu Pan; Yu-Wen Zhao; Jun-Pu Mei; Zheng-Huan Fang; Yige Wang; Xun Zhou; Yang-Jie Zhou; Rui Zhang; Kai-Lin Zhang; Li Jiang; Qian Zeng; Yan He; Zheng Wang; Zhen-Hua Liu; Qian Xu; Qi-Ying Sun; Yang Yang; Ya-Cen Hu; Ya-Se Chen; Juan Du; Li-Fang Lei; Hai-Nan Zhang; Chun-Yu Wang; Xin-Xiang Yan; Lu Shen; Hong Jiang; Jie-Qiong Tan; Jin-Chen Li; Bei-Sha Tang; Ji-Feng Guo
Journal:  Transl Neurodegener       Date:  2020-08-04       Impact factor: 8.014

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.